Login
Enovis Corp logo

Enovis Corp

enovis.com

Enovis Corp (NYSE: ENOV) is a medical technology company. The filing excerpts provided do not contain sufficient detail to construct a fully source-grounded canonical description covering revenue model, segment breakdown, competitive position, headquarters, founding year, or leadership. All available excerpt content relates only to SEC cover-page boilerplate from the 10-K filed 2026-02-26 (accession 000142080026000012) for fiscal year ended December 31, 2025, and does not include the substantive business description sections required to meet the writing standards. A description cannot be responsibly completed from these excerpts alone.

Financial Snapshot

Revenue
TTM
$2.261B
Gross Margin
TTM
60.18%
Net Income
TTM
-$672.6M
Current Assets
2026 Q2
Current Liabilities
2026 Q2
Current Ratio
2026 Q2
203.67%
Total Assets
2026 Q2
Total Liabilities
2026 Q2
Book Value
2026 Q2
$1.479B
Cash
2026 Q2
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$41.23M

Stock Price

Loading...
Market Cap: $1.6779 Billion

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support